New study led by Dr. Jianping Huang uses uses novel approach to halt or even shrink late-stage tumors such as glioblastoma, ovarian cancer and pancreatic cancer.
Renovations to the MBI’s ground floor provide investigators access to the most up-to-date state-of-the-art facilities.
Dr. David Vaillancourt leads international study demonstrating that a non-invasive, automated MRI method can pinpoint various types of Parkinson’s disease and Parkinson’s-like syndromes.
Expert neuroscientists who study age-related memory loss at all four McKnight Brain Institutes in the U.S. came together in Gainesville for 11th annual meeting.
Maryam Rahman, M.D., was named the 2019 Preuss Research Award winner during the American Association of Neurological Surgeons annual scientific meeting.
Tony Wyss-Coray, Ph.D., a professor of neurology and neurological sciences at Stanford University, will deliver the keynote address for the McKnight Inter-institutional Meeting at 10 a.m. Thursday, April 11 at the Harrell Medical Education Building (Room LS 125). Wyss-Coray will discuss the systemic regulation of brain aging and neurodegeneration.
In the laboratory of David Vaillancourt, Ph.D., researchers are applying a groundbreaking, noninvasive imaging biomarker they identified to discover better diagnostics and treatment of Parkinson's disease.
Three renowned neuroscientists from top U.S. research institutions — Drs. Malú G. Tansey, Ph.D., Matthew LaVoie, Ph.D., and Stefan Prokop, M.D. — will join the newly established Norman Fixel Institute for Neurological Diseases at UF Health.
UF neuroscience students spread to public schools this week and hosted field trips at UF’s McKnight Brain Institute and academic health center.
NIAA Director Dr. George Koob discussed the state of alcohol use disorders in the U.S. and the pursuit of new treatment targets during the seventh annual Luttge Lectureship in Neuroscience.